AI-Optimized Nuclear Power Licensing Program
Sector: Nuclear • Location: United States
Source: Bitget
Microsoft and Nvidia launched the 'AI for nuclear' program to optimize the nuclear power project licensing and approval process using AI technology. This program aims to reduce the nuclear power license approval cycle by 92%, accelerating the deployment of advanced nuclear technologies like Small Modular Reactors (SMRs) to provide stable and low-carbon electricity for AI data centers.
- Status
- Closed
- Sector
- Nuclear, Power Generation (CCGT)
- Location
- United States of America
- Updated
- 22 Jul 2026
- Source
- Bitget
ConstructChat
Ask ConstructChat about AI-Optimized Nuclear Power Licensing Program
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | launched |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Microsoft and Nvidia launched the 'AI for nuclear' program to optimize the nuclear power project licensing and approval process using AI technology. This program aims to reduce the nuclear power license approval cycle by 92%, accelerating the deployment of advanced nuclear technologies like Small Modular Reactors (SMRs) to provide stable and low-carbon electricity for AI data centers. |
Original sector | Energy |
Location
Country | United States of America (USA) |
Source
Source | Bitget |
URL |
More Details
Record type | Project |
Sector | Nuclear, Power Generation (CCGT) |
Article published date | 2026-03-27 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Nuclear projects in United States
- Barksdale Air Force Base, Louisiana
- Kings Bay Naval Submarine Base
- Gatorade Plant, Pepsi Co, Oklahoma
- ImClone Systems Biopharmaceutical Plant, New Jersey, US
- Novavax Vaccine Plant
- Gibbs Cancer Centre and Research Institute, Pelham, South Carolina
- Hovione API Facility Expansion, East Windsor, New Jersey
- Cascade Chemistry’s Manufacturing Facility Expansion, Eugene
